BMS recently updated its 340B restrictions to exempt a new state and add a new drug.

BMS Exempts New Mexico CHCs from CP Restrictions and Claims Data Reqs, Adds Drug to Policy

September 29, 2026 Shannon Young, Managing Editor 340B Report Views

A New Jersey-based drugmaker recently added a multiple myeloma drug to its 340B contract pharmacy restrictions and announced that its [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!